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The individual molecular pathways downstream
of Cdc42, Rac, and Rho GTPases are well docu-
mented, but we know surprisingly little about how
these pathways are coordinated when cells move
in a complex environment in vivo. In the developing
embryo, melanoblasts originating from the neural
crest must traverse the dermis to reach the
epidermis of the skin and hair follicles. We previously
established that Rac1 signals via Scar/WAVE and
Arp2/3 to effect pseudopod extension and migration
of melanoblasts in skin. Here we show that RhoA
is redundant in the melanocyte lineage but that
Cdc42 coordinates multiple motility systems inde-
pendent of Rac1. Similar to Rac1 knockouts,
Cdc42 null mice displayed a severe loss of pigmen-
tation, and melanoblasts showed cell-cycle progres-
sion, migration, and cytokinesis defects. However,
unlike Rac1 knockouts, Cdc42 null melanoblasts
were elongated and displayed large, bulky pseudo-
pods with dynamic actin bursts. Despite assuming
an elongated shape usually associated with fast
mesenchymal motility, Cdc42 knockout melano-
blasts migrated slowly and inefficiently in the
epidermis, with nearly static pseudopods. Although
much of the basic actin machinery was intact,
Cdc42 null cells lacked the ability to polarize their
Golgi and coordinate motility systems for efficient
movement. Loss of Cdc42 de-coupled three main
systems: actin assembly via the formin FMNL2 and
Arp2/3, active myosin-II localization, and integrin-
based adhesion dynamics.624 Current Biology 27, 624–637, March 6, 2017 ª 2017 The Author(
This is an open access article under the CC BY-NC-ND license (http://INTRODUCTION
During development of the mouse embryo, melanoblasts derive
from neural crest cells following closure of the neural tube. They
migrate through the dermis and cross the basement membrane
into the epidermis at around embryonic day 12.5 (E12.5) [1]
before homing to hair follicles [2, 3]. Melanoblasts use Rac1 to
drive actin assembly and extension of pseudopods, which are
stabilized by the actin-bundling protein fascin [4, 5]. Migration
in the epidermis is individual and seemingly random [4, 6].
Epidermal melanoblasts move between keratinocytes along
the epidermal basement membrane [7]. Here we explored the
role of Cdc42 in melanoblast migration and population of mouse
embryo skin.
Our insight into Cdc42 function in multicellular organisms is
still limited, but generally supports a role in epithelial polarity
and actin dynamics. Cdc42 is important for epithelial morpho-
genesis, early cell polarity, and spindle orientation during the
development of Drosophila melanogaster and Caenorhabditis
elegans [8, 9]. Global Cdc42 knockout in mice caused embryonic
lethality before E5.5 [10]. Cdc42 null embryonic stem cells
proliferated normally but had cytoskeletal defects [10].
Knockout of Cdc42 in the murine neural crest, using Wnt-1
Cre, allowed survival until E13.5 with severe craniofacial and car-
diac abnormalities [11]. These defects were attributed at least in
part to aberrant actin dynamics, altered cell migration, and bone
morphogenetic protein 2 signaling [12]. However, loss of Cdc42
or Rac1 did not prevent neural crest cells from reaching their
targets by E10.5 or growing out of the neural tube in culture
[11]. Thus, Cdc42 is implicated in development, but its role in
migration in vivo is not clear.
Here we describe a distinct role for Cdc42 in the regulation of
pseudopod dynamics and adhesion during melanoblast migra-
tion. Cdc42 null melanoblasts extended long blebbing pseudo-
pods, which were not very dynamic. Despite their static nature,s). Published by Elsevier Ltd.
creativecommons.org/licenses/by-nc-nd/4.0/).
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Cdc42 null pseudopods showed regular bursts of actin assem-
bly and elevated levels of Rac signal activation but ineffective
protrusion. Loss of Cdc42 also caused a severe defect in focal
adhesion assembly and dynamics and a de-localization of active
myosin. Thus, we propose that in addition to a strong role in cell
proliferation, Cdc42 has a coordinating role in melanocytic cell
migration, impacting on multiple systems that need to work
together for effective cell translocation.
RESULTS
Loss of Cdc42 in the Melanocyte Lineage Leads to Coat
Color Defects
Cdc42 was removed from the melanocyte lineage by crossing
mice in a C57BL/6 background carrying two floxed alleles of
Cdc42 (Cdc42 f/f) [13] with C57BL/6 mice expressing Cre re-
combinase under the control of the tyrosinase promoter
(Tyr::CreB+) [14] (Figure 1A). Cdc42 f/f; Tyr::CreB+ mice were
born at the expected Mendelian ratio. They were culled between
postpartum day 14 (P14) and P30, as they were slightly shaky
and runted, similar to Rac1 f/f Tyr::Cre mice [4].
All Cdc42 f/f; Tyr::CreB+mice (N = 20) displayed a white patch
running down the ventral midline, covering half to most of the un-
derside (Figure 1B). Small white patches often appeared along
the dorsal midline (Figure 1B, yellow arrows). Pigmented areas
contained frequent white hairs, and the paws and tails were hy-
popigmented (Figure 1B). Skin cross-sections from P13 mice
revealed a lack of melanocytes in hair follicles of white patches
but not pigmented areas in both control (Ctr) and Cdc42 f/f;
Tyr::CreB+ mice (Figure 1C, pink stain). Thus, Cdc42 nulls had
fewer melanocytes in hair follicles in areas distal to the neural
tube but fairly normal melanocyte distribution on the back,
similar to Rac1 deletion [4].
In contrast to the dramatic phenotype of Cdc42 f/f; Tyr::CreB+
mice, deletion of RhoA using Tyr::CreB+ had no overt effect on
coat color in mice up to P14 (Figure S1A). RhoA f/f; Tyr::CreB+
mice were born at the expected Mendelian ratio and showed
no coat color defects, shakiness, or runty phenotype, suggesting
that RhoA is dispensable for melanocyte development.
Cdc42 Null Melanoblasts Fail to Fully Populate the
Developing Mouse Embryo
To investigate the cellular mechanisms driving pigmentation de-
fects, Cdc42 f/f; Tyr::CreB+ melanoblasts were visualized using
the reporter DCT::LacZ [2]. Tyrosinase expression begins around
E10.5 [14, 15], when melanoblasts appear around the neural
tube in the migration staging area. Control and Cdc42 f/f;
Tyr::CreB+; DCT::LacZ (Cdc42 f/f) embryos had similar numbers
of melanoblasts at E11.5 (Figures 2A and 2B). At E13.5, the lead-
ing wave of melanoblasts in controls and Cdc42 flox heterozy-
gotes Cdc42 f/+; Tyr::CreB+ had reached midway around the
embryo and part of the way down the developing limbs, whereasFigure 1. Loss of Cdc42 in the Melanoblast Lineage Leads to Coat Co
(A) Schematic of the gene-targeting strategy for Cdc42 f/f; Tyr::CreB+ mice.
(B) Coat color of control Cdc42 wt/wt (Ctr) mice and Cdc42 f/f; Tyr::CreB+ mice
(C) Sections from dorsal and ventral Ctr and Cdc42 f/f; Tyr::CreB+ pup skin stain
bars, 100 mm. The far-right panels show hair follicles. N = 20 mice.
See also Figure S1.
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melanoblasts in all areas (boxes, Figures 2C–2F and Figure S1B).
By E15.5, melanoblasts in control embryos had spread around
the entire embryo and down the developing limbs, but in Cdc42
f/f; Tyr::CreB+ embryos, melanoblasts had only populated
partway around the belly and halfway down the developing
limb (Figures 2G and 2I; Figure S1C). Cdc42 null cells accumu-
lated around/in hair follicles in places but less efficiently than
controls (Figure 2I). Thus, Cdc42 is a major controller of melano-
blast proliferation and spread throughout the skin in vivo.
Although loss of Cdc42 caused severe defects in melanoblast
population of the skin, there is also striking resiliency within the
system, as some of the knockout cells could clearly populate
hair follicles and give rise to pigmentation of areas of the mouse
skin. Knockout cells also traversed the basement membrane
from the dermis to the epidermis normally, with around 20%
of cells still in the dermis at E13.5 and >90% of cells in the
epidermis by E15.5 (Figure S2).
Cdc42 Controls Melanoblast Cell-Cycle Progression
and Cytokinesis
Because Cdc42 mutant embryos showed a paucity of
melanoblasts, we investigated possible defects in cell-cycle pro-
gression and cytokinesis. Staining for Ki67 revealed normal
proportions of Cdc42 f/f cells in cycle (Figure 3A; yellow
arrows, +Ki67; white arrow, Ki67), but BrdU staining at 2 and
24 hr revealed slower cell-cycle progression in Cdc42 f/f (Figures
3B and 3C; yellow arrows, +BrdU; white arrows, BrdU). We
saw no cleaved caspase-3-positive (apoptotic) cells in control
or Cdc42 null skins. Thus, loss of Cdc42 delays the cell cycle
of melanoblasts.
We developed immortalized melanocyte cell lines cultured
from P1 pups with Cdc42 f/f; Rosa26::Cre-ERT2; CDKN2/ to
allow conditional deletion of Cdc42 with OHT (4-hydroxytamox-
ifen) in culture [4]. Hereafter, we refer to these lines as EW1,
EW2.1, EW2.2, and EW7. These lines behaved similarly, and
many experiments were repeated with at least two lines. Addi-
tion of OHT induced a loss of Cdc42 protein over 5 days (Fig-
ure 3D). Cdc42 null melanocytes had an increased doubling
time in vitro (Figure 3E) and accumulated in G1 (Figures 3F and
3G). Thus, cell-cycle progression defects likely contribute to
the paucity of melanoblasts in Cdc42 f/f; Tyr::CreB+ embryos.
In addition, time-lapse imaging of live cells in embryo skin ex-
plants from Cdc42 f/f; Tyr::CreB+; Z/EG (driving melanoblast-
specific expression of GFP) [16] revealed that Cdc42 null mela-
noblasts have an approximately 3-fold increased division time
(Figures S3A and S3B;Movie S1) from cleavage furrow formation
(Figure S3A, green boxes) to separation of daughter cells (Fig-
ure S3A, red boxes; Figure S3C). Both EW1 and EW7 also spent
2.5 times longer from rounding up to cytokinesis (Figures S3D
and S3E; Movie S2). Thus, Cdc42 null melanoblasts struggle
to physically separate from each other after division. Theselor Defects in Adult Mice
at P22. Yellow arrows indicate dorsal white patches.
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Figure 2. Loss of Cdc42 in the Melanoblast Lineage Delays Dorsal-to-Ventral Population of the Skin after E11.5
Photos show X-gal-stained Ctr and Cdc42 f/f embryos at various stages as indicated. In all panels, Ctr indicates Cdc42 wt/wt; DCT::LacZ controls, whereas
Cdc42 f/f indicates Cdc42 f/f; Tyr::CreB+; DCT::LacZ.
(A) E11.5 embryos; dashed lines denote the quantification area. Scale bar, 1 mm.
(B) Number of melanoblasts in E11.5 embryos.
(C) E13.5 embryos; dashed lines denote melanoblast progress. Scale bar, 1 mm.
(D) Quantification area example.
(E) E13.5 embryos with quantification area. Scale bar, 1 mm.
(F) Melanoblasts from box 1 (most dorsal) to box 6 (ventral) at E13.5.
(G) E15.5. Scale bar, 1 mm. The dashed line indicates the border where the furthest migrating melanoblasts from the neural tube have appeared.
(H) Melanoblasts counted in boxes 1–6 as shown in (D) at E15.5.
(I) Zoom-in of E15.5 embryos. Scale bar, 200 mm.
Mean ± SEM. NR 4 embryos from three litters. Kruskal-Wallis one-way ANOVA test, *p < 0.05, **p < 0.01, ***p < 0.001; n.s., not significant. See also Figure S2.
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Figure 3. Cdc42 Null Melanoblasts and Melanocytes Show Cell-Cycle Progression Defects
(A–C) Representative images of transverse sections of control (Ctr, Cdc42 wt/wt; Tyr::CreB; Z/EG; top) and Cdc42 f/f (Cdc42 f/f; TyrCreB; Z/EG; bottom) E15.5
embryo skin stained with DAPI (blue), DCT (green), and either Ki67 (red) or BrdU (red) at 2 or 24 hr as indicated. Yellow arrows indicate proliferating melanoblasts;
white arrows indicate non-proliferating melanoblasts. NR 3 separate embryos. t test with Welch’s correction. Scale bar, 10 mm.
(A) Ki67-positive cells as indicated; n.s., p = 0.38.
(B) 2 hr BrdU-positive cells as indicated; n.s., p = 0.06.
(C) 24 hr BrdU-positive cells as indicated; *p = 0.014.
(D) Western blot showing OHT-induced Cdc42 deletion (GAPDH loading control) in EW1 and EW7 Cdc42 f/f; ROSA26::Cre-ERT2; CDKN2/cells.
(E) Melanocyte proliferation assay of control (DMSO-treated) and Cdc42 f/f (OHT-treated) cell lines (EW1 and EW7). Error bars show SEM fromN = 3 experiments
in triplicate.
(F) Representative plot from flow-cytometry analysis of EW7 following mock treatment (DMSO) or deletion (OHT) of Cdc42.
(G) Quantification of cells in cycle. N = 3. Error bars show SEM. **p = 0.0039 (G1 phase), **p = 0.0017 (S phase).
See also Figure S3.
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problems likely compound the reduction in numbers of melano-
blasts in embryos and contribute to the coat color defects of
adults.
Loss of Cdc42 Uncouples Actin Dynamics and
Pseudopod Extension from Migration
To investigate whether Cdc42 null melanoblasts had migration
defects, we imaged melanoblasts migrating in ex vivo skin sec-
tions from Cdc42 f/f; Tyr::CreB+; Z/EG. Control melanoblasts in
E15.5 embryo skin displayed multiple, highly dynamic pseudo-
pods that extended between surrounding keratinocytes (Fig-
ure 4A, yellow arrows). Cdc42 null melanoblasts, in contrast, dis-
played long wavy non-dynamic pseudopods (Figure 4A, red
arrow; Movie S3). Cdc42 null melanoblasts showed an increase
of around 40% spread area (Figure 4B). Additionally, Cdc42 null
cells frequently had only one or two pseudopods, with 56% ap-
pearing bipolar (Figure 4A, orange arrow; Figure 4C). The length-
to-width ratio of Cdc42 nulls was increased (Figure 4D), as was
pseudopod length (Figure 4E). We were unable to reliably mea-
sure persistence, as the density of melanoblasts in wild-type
skin was too high. Cdc42 null cells showed very long lived pseu-
dopods, with 10% lasting the entirety of the 4-hr time-lapse
movie, compared with 5–80 min for controls (Figure 4F). Nor-
mally, elongation of cells is a hallmark of rapid migration, but
Cdc42 null cells displayed a 2-fold decrease in speed from
around 0.4 to 0.2 mm/min (Figure 4G). Thus, Cdc42 null cells
are elongated, but move only slowly in epidermis.
To determine whether a loss of actin dynamics might be
responsible for the slow motility, we crossed Cdc42; Tyr::CreB+
with the Lifeact-GFP transgene [17] to observe filamentous actin
dynamics. Bursts of actin occurred at the tips of both control and
knockout pseudopods, driving them forward (Figure 4H; Movie
S4). There was a small but significant increase in the time be-
tween actin bursts in knockout pseudopods from 9.0 ± 0.8 min
SEM (Ctr) to 11.6 ± 0.7 min SEM (Cdc42 f/f) (Figure 4I), and cells
appeared not to translocate as often or as rapidly following a
burst (Movie S4). Actin bursts were usually accompanied by pro-
trusion of the pseudopod, but this was impaired in Cdc42 nulls
(Figure 4J). There was a linear correlation between the lifetime
of a pseudopod and the number of actin bursts (Figure 4K).Figure 4. Cdc42 Null Melanoblasts Have Migration Defects and Altered
(A) Still images of Ctr (Cdc42 wt/wt; Tyr::CreB+; Z/EG) and Cdc42 f/f (Cdc42
pseudopods; the red arrow indicates a blebby pseudopod; and the orange arrow
(B–F) N = 125 cells per genotype, from 301 control pseudopods and 239 Cdc42
(B) Cell area.
(C) Number of pseudopods.
(D) Length-to-width ratio.
(E) Pseudopod length in microns.
(F) Pseudopod lifetime in minutes.
(G) Migration speed. Dashed vertical lines indicate average speed. N = 115 cells
(H) Representative images of melanoblast F-actin in control Lifeact-GFP lox-sto
Tyr::CreB+ (Cdc42 f/f) skin explants (see Movie S4). Scale bar, 10 mm.
(I) Number of minutes between actin bursts in Ctr (9.0 ± 0.8 min SEM) and Cdc4
(J) Action of pseudopods within three frames (3 min) following an actin burst. Ex
pseudopods that protruded, retracted, or remained following an actin burst (with
skins.
(K) Scatterplots showing pseudopod lifetime versus actin bursts. The line of best fi
N = 5–6 embryos from four different litters, except (J), where N = 20 cells, ove
*p < 0.05, **p < 0.01, ***p < 0.001, t test.
630 Current Biology 27, 624–637, March 6, 2017Thus, the frequency of actin bursting was not greatly affected
by the loss of Cdc42, but the coupling with protrusion was lost.
Cdc42 Knockout Melanocytes Fail to Coordinate Actin
Dynamics, Myosin Localization, and Migration
All cultured melanocyte lines were confirmed to be over 90%
pure by staining with the melanocyte lineage factor MITF (Fig-
ure S4A shows EW7 as an example). Control cells formed large
lamellipodia on fibronectin surfaces, with a length-to-width ratio
close to 1, and moved at an average speed of 0.4 mm/min.
Following deletion of Cdc42 (OHT), cells were almost stationary,
with an elongated spindle shape and an average speed of
0.014 mm/min (Figures 5A–5C). As in skin explants, these thin,
long protrusions were very stable, with the majority lasting over
600 min (Figure 5D). The increased length-to-width ratio was
rescued through transient expression of Cdc42-YFP in knockout
cells (Figures S4B and S4C). Thus, cultured melanocytes
behaved similar in vitro to live skin explants and to Cdc42-
depleted fibroblast cell lines [13].
Cdc42 has a well-described role in mediating the polarization
of the Golgi complex in front of the nucleus in a moving cell [18],
so we tested whether Cdc42 null melanocytes retained this abil-
ity. When cells were allowed to migrate out of a crowded space
(see Supplemental Experimental Procedures), around 80% of
the control cells reoriented their Golgi to face the direction of
migration. However, Golgi orientation was random in Cdc42
null cells (Figures 5E and 5F). Additionally, the Golgi appeared
more diffuse, and frequently spread over multiple segments
of a 120 divided mask placed over the cell (Figure 5G). Thus,
Cdc42 regulates Golgi polarity during motility of melanocytes,
as previously described in other cell types [13, 18].
In addition to their polarity defects, Cdc42 null melanoblasts
resembled blebbistatin-treated cells in embryo skin explants
[4] with blebby static pseudopods. Cdc42 is linked to myosin
activation via the myotonic dystrophy kinase-related MRCK ki-
nases (reviewed in [19]), suggesting that pseudopod retraction
defects may be due to reduced activation of myosin light
chain (MLC). However, levels of MLC phosphorylation at T18/
S19 were unaltered in Cdc42 null melanocytes (Figures S4D
and S4E). Despite this, localization of p-MLC was abnormallyPseudopod Dynamics
f/f; Tyr::CreB+; Z/EG) skin explants (see Movie S3). Yellow arrows indicate
denotes the ‘‘bipolar’’ phenotype. Scale bars, 10 mm.
f/f pseudopods.
per genotype.
p-lox; Tyr::CreB+ (Ctr) skin explants and Lifeact-GFP lox-stop-lox; Cdc42 f/f;
2 f/f (11.6 ± 0.7 min SEM) pseudopods. N = 100 pseudopods per genotype.
tension, ‘‘protrude’’; retraction, ‘‘retract’’; and static, ‘‘remain.’’ Percentage of
in three frames) was a calculated per skin from at least eight bursts from four
t for Ctr has slope 7.2 ± 0.7, R2 = 0.55; for Cdc42 f/f, slope 10.8 ± 0.6, R2 = 0.77.
r three experiments. Boxplots show mean, minimum, and maximum values.
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concentrated toward the cell body of Cdc42 null cells, rather
than peripheral in the lamellar region, as in the controls (Figures
S4F and S4G). We also performed a blebbistatin wash-out
experiment to test the sensitivity of Cdc42 null cells to inhibition
of myosin-II (Figures S4H and S4I). Control cells (Cdc42 wt [wild-
type]) became elongated and resembled Cdc42 null cells before
blebbistatin treatment. Cdc42 nulls, however, showed very little
change in shape, indicating that their myosin-II was already
not engaged. Thus, although overall levels of p-MLC were not
dramatically altered in Cdc42 nulls, p-MLC was mislocalized
and Cdc42 null cells resembled blebbistatin-treated cells and
showed very little response to blebbistatin treatment.
We next investigatedwhether loss of Cdc42 affected themajor
actin organizers Scar/WAVE and Arp2/3 complex as well as the
Cdc42 target formin FMNL2 [20]. Both Arp2/3 andWAVE2 local-
ized in a broad band in lamellipodia of control cells (Figure 5H),
but in Cdc42 null cells they formed small patches near the cell
edge (Figure 5I), in protrusions (Figure 5I, insets). Because
FMNL2 is a Cdc42 target regulating lamellipodial actin [20], we
tested whether constitutively active FMNL2 might rescue the
loss of Cdc42. Endogenous FMNL2 localized prominently in la-
mellipodia and filopodia of both normal and Cdc42 null melano-
cytes (Figure 6A). Cells expressing constitutively active FMNL2
showed increased spreading but also a more fenestrated
appearance (Figures 6B–6E). In particular, mutant FMNL2-GFP
constructs FMNL2-DDAD-GFP and FMNL2-A272E-GFP (see
Supplemental Experimental Procedures), which both lack the
autoinhibitory regulation provided by the diaphanous autoinhibi-
tory domain (DAD) region, rescued the length-to-width ratio (Fig-
ure 6C). We scored cells in shape categories (see the legend of
Figure 6). Expression of active FMNL2-GFP increased the pro-
portion of cells with a wider lamellipodial shape and decreased
the proportion classified as elongated (Figure 6D). Wild-type
FMNL2-GFP [20] and both active constructs gave a partial
rescue of roundness (Figure 6E). Thus, a major part of the cell
shape change that we observe upon loss of Cdc42 appears to
be due to the inability of cells to activate FMNL2.
We next used fluorescence lifetime imaging microscopy
(FLIM) imaging of a Rac1FLARE dual-chain (dc) biosensor to
determine whether loss of Cdc42 decreased Rac1 activation
signals. Lifetime heatmaps of control dTurquoise (donor alone)
or Rac1FLARE.dc showed a decreased lifetime, demonstrating
Fo¨rster resonance energy transfer (FRET) (Figure S4J). The
percentage FRET efficiency in Cdc42 knockout cells was to
our surprise higher, indicating an increase in Rac1 signaling ac-
tivity (Figure S4J). We also performed a biochemical pull-downFigure 5. Primary Melanocytes Require Cdc42 for Efficient Pseudopod
All panels show EW7 Cdc42 f/f; ROSA26::Cre-ERT2; CDKN2/ melanocytes tre
(A) Melanocytes on fibronectin. Scale bar, 30 mm.
(B) Length-to-width ratio (N = 59 cells per condition).
(C) Migration speed (N = 90 cells per condition).
(D) Pseudopod lifetime (N = 57 pseudopods per condition).
(E) Nuclei (DAPI, blue), GM130 (Golgi, green), and F-actin (Alexa Fluor 568-phallo
quantification segments.
(F and G) Percentage of cells with Golgi polarized (F) and percentage of Golgi sp
condition over three experiments.
(H and I) DMSO-treated (H) and OHT-treated (I) EW7 F-actin (phalloidin, green) an
Scale bar, 15 mm.
Graphs show mean ± SEM. **p < 0.01, ***p < 0.001, ****p < 0.0001, t test. See a
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ference in Rac1 signaling activity between control and Cdc42
null cells. The FRET assay is more sensitive, so this likely
means that there is a small or localized increase in Rac1 activity
detectable only by FRET. Thus, the pathways that regulate
Rac1 activation were active in Cdc42 null cells, despite cells
being unable to use their actin dynamics productively for
migration.
Taken together, Cdc42 null cells still showed active Rac
signaling but a failure to organize Arp2/3, Scar/WAVE, FMNL2,
and activemyosin-II in their protrusions; thus, the variousmotility
systems seemed intact, but uncoupled from movement.
Cdc42 Coordinates Adhesion Dynamics for Effective
Migration
Adhesion controls the shape andmigratory properties of cells, as
well as their growth state. Global RNA sequencing was per-
formed on Cdc42 f/f; ROSA26:Cre-ERT2; CDKN2/melanocyte
lines (EW2.1 and EW2.2, isolated from littermate pups) to probe
pathways affected by Cdc42 loss (Figure S5A; Data S1). Biolog-
ical replicates were consistent by principal component analysis
(PCA) of the data (Figure S5B). DAVID (https://david.ncifcrf.
gov/) gene ontology analysis of significantly (padjusted < 0.05)
downregulated (290) or upregulated (343) genes identified lyso-
somal pathways as significantly upregulated, and hierarchical
clustering identified top consistent hits (Figures S5C and
S5D). Additionally, ‘‘pathways in cancer,’’ ‘‘focal adhesion,’’
and ‘‘regulation of the actin cytoskeleton’’ (Figure S5E) were
significantly downregulated. Hierarchical clustering analysis of
KEGG (Kyoto Encyclopedia of Genes and Genomes) ‘‘focal
adhesion’’ genes showed consistency between EW2.1 and
EW2.2 (Figure S5F). a4 integrin showed the largest fold change
(2.93 ± 0.5), which we confirmed at the protein level (Figures
S5G and S5H). Additionally, b3 integrin was decreased at the
protein level (Figures S5I and S5J), despite an increase at the
RNA level (+2.01 ± 0.7, padjusted = 0.2; Data S1). The expression
levels of classical Rho-GTPases remained relatively unchanged
in Cdc42 knockout cells (Figure S5K).
As suggested by global RNA-sequencing analysis and cell-
shape abnormalities, Cdc42 null cells showed adhesion defects.
Control melanocytes displayed a belt of multiple large adhesions
underneath their lamellipodia thatwere rich in vinculin (Figure 6F),
phospho-paxillin (Figure S6A), and b1 integrin (Figure S6E),
whereas knockout melanocytes displayed only a few small ad-
hesions with the same components (Figure 6F; Figures S6A
and S6E). Overall, knockout melanocytes had fewer adhesionsExtension and Ruffling but Not for Rac1 Activation
ated with DMSO (control) or OHT (Cdc42/).
idin, red) of migrating melanocytes. Scale bars, 10 mm. Arrows show example
read (G) over one, two, or three segments. N = 353–386 cells; 15 regions per
d Arp2/3 complex (p34) or WAVE2 (red). Insets show leading-edge protrusions.
lso Figure S4.
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per cell, a smaller average adhesion size, and fewer adhesions
per cell area (Figures 6G–6I; Figures S6B–S6D).
Because FMNL2 partially rescued the cell-shape defects of
Cdc42 null cells, we asked whether it affected focal adhesions.
Indeed, active FMNL2 expression increased the number of ad-
hesions per cell (Figure S6F) and area of adhesions (Figure S6G)
but not the number of adhesions per cell area, as FMNL2 expres-
sion increased the spread area quite significantly (Figure S6H).
These changes were modest and might have complex reasons,
but expression of FMNL2 appeared to give a partial rescue.
Live imaging of GFP-paxillin or mApple-vinculin revealed that
control melanocytes dynamically extended lamellipodia sup-
ported by nascent adhesions, whereas adhesions of Cdc42 nulls
were smaller and less dynamic. Adhesions in knockout melano-
cytes showed a slower assembly rate with GFP-paxillin and a
slower disassembly rate with both GFP-paxillin and mApple-vin-
culin, indicating reduced adhesion dynamics in Cdc42 knockout
cells (Figures 7A–7E; Figure S7A). Re-expression of a4 integrin in
Cdc42 null cells gave a partial rescue (Figure 7F). The length-to-
width ratio and number of adhesions per cell did not change
significantly, but the roundness and total cell area increased
modestly (Figures 7G–7J). Thus, a4 integrin levels account for
part of the phenotype of Cdc42 null melanocytes.
Cdc42 nulls also showed spreading defects on fibronectin or
laminin but not concanavalin A, a lectin mediating integrin-inde-
pendent adhesion [21] (Figures 7K–7M) and formation of fewer
adhesions (Figures S7B, S7C, and S7E). Because filopodia-like
protrusions during cell spreading are linked with nascent b1 in-
tegrin adhesions [22], we measured filopodia-like structures
(FLSs) in cells spreading on fibronectin. Knockout melanocytes
formed fewer, shorter FLSs (Figures S7D, S7F, and S7G) and
showed a thicker band of cortical actin than controls (Figure S7D,
white arrows), possibly reflecting less dynamic actin. Thus,
Cdc42 null melanoblasts are defective in adhesion-dependent
spreading, with fewer dynamic adhesions and misregulation of
both localization and expression of focal adhesion components.
DISCUSSION
Loss of Cdc42 in the melanocyte lineage gave a phenotype of
similar severity to loss of Rac1, but with multiple unique features
revealingCdc42 as a complex organizer ofmotility systems.Both
GTPases appear important for melanoblast proliferation and
migration during embryogenesis, but Cdc42 null cells were exag-
geratedly elongated in vivo, rather than rounded, like Rac1 nulls
[4]. Cell shape has been proposed as a potential predictor of
metastasis in melanoma [23–26], but in the case of control byFigure 6. Cdc42 Null Cells Have Morphological Defects Involving the F
All panels show EW7 Cdc42 f/f; ROSA26::Cre-ERT2; CDKN2/ melanocytes tre
(A) Control and OHT-treated EW7 cells stained for endogenous FMNL2 and F-ac
(B) EW7 cells expressing FMNL2 constructs as indicated.
(C) Length-to-width ratio.
(D and E) Proportion of cells in different shape categories (D) and roundness (E)
compare data to the EW7 OHT GFP condition.
(F) Control and OHT-treated EW7 cells stained for vinculin and F-actin.
(G–I) Adhesion number per cell (G), adhesion area (H), and number of adhesions no
N = 29–33 cells per condition over three experiments.
Graphs (C, E, G, H, and I) showmean ± SEM. **p < 0.01, ***p < 0.001, ****p < 0.0001
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correlation between shape and migration properties. Similar to
Rac1, Cdc42 also plays a key role in promoting G1-to-S phase
transition in melanocytic cells in vivo (Figure 3). Rac1 and
Cdc42 have a well-established role in cell-cycle progression in
cultured cells [27]. Cdc42 has a more direct role in cytokinesis
than Rac, as it localizes on the spindle and kinetochores during
mitosis [27]. Our observations that Cdc42 impacts on localization
of phosphorylated myosin light chain suggest possible implica-
tions for cytokinesis. Curiously, proliferation and migration de-
fects are generally coupled in melanoblasts in vivo [4, 5, 28],
perhaps due to a metabolizable signal in the skin or coupling of
the mitotic spindle to the cell cortex by motility proteins [29].
At the cellular level, loss of Cdc42 had a pleiotropic effect,
causing defects in the organization and coordination of actin dy-
namics, contractile activity, and adhesion. Despite evidence of a
hierarchy whereby Rac1 is activated downstream of Cdc42 in
some systems, melanocytic Cdc42 null cells showed elevated
Rac1 activation but only small lamellipodia. Their pseudopod ex-
tensions were not dynamic in vivo despite actin bursts visualized
with Lifeact-GFP, and they failed to assemble broad lamellipodia
driven by the formin FMNL2 [20], Scar/WAVE, and Arp2/3 in vitro.
Myosin-II was still phosphorylated at normal levels, indicating
signaling to activation, but it was not localized properly and cells
resembled the blebbistatin-treated state. Previous studies con-
nected Cdc42 and actin polymerization with phosphoinositides,
p21-activated kinase (PAK) kinases, and N-WASP [30]. How-
ever, neither N-WASP nor PAK kinases affected pseudopod
dynamics or migration of melanoblasts in skin explants [4].
Cdc42 null melanocytes showed adhesion defects, unlike
Cdc42 null mouse embryonic fibroblasts (MEFs), which spread
normally and had normal (b1 or b3, or a1, 2, 5, 6, or v) integrin
subunit expression levels [13]. In contrast, Cdc42 null melano-
cytes showed reduced adhesion dynamics only partially rescued
by re-expression of a4 integrin or FMNL2 active mutants.
Despite adhesion and spreading defects in vitro, melanoblasts
null for Cdc42 could still cross and interact with the epidermal
basement membrane in vivo (Figure S2).
In addition to adhesion changes, several genes in a KEGG
lysosomal pathway were upregulated at the RNA level in
Cdc42 null melanocytes, including several subunits of ATP6vo,
a vacuolar ATPase (V-ATPase) required for proton pumping in
acidic organelles such as the lysosome (Figure S5). V-ATPase
is linked to anoikis resistance of cancer cells [31] due to its ability
to degrade internalized integrins. Thus, Cdc42 null cells may
have increased ability to degrade internalized integrins, which
would also contribute to diminished levels of a4 and b3 integrins.ormin FMNL2 and Focal Adhesions
ated with DMSO (control) or OHT (to delete Cdc42).
tin. White boxes denote zoom-in.
was calculated; N = 31–37 cells per condition over three experiments; t tests
rmalized to the cell area (I) were calculated using thresholded vinculin staining.
, t test withWelch’s correction. Scale bars, 10 mm. See also Figures S5 and S6.
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Mouse melanocytes express Cdc42, Rac1, RhoA, and RhoC
at high levels and RhoB, RhoG, RhoJ, and RhoQ at lower levels
(Figure S5K; Data S1), which were not affected by deletion of
Cdc42. RhoG has some overlapping functions with Rac1 and
Cdc42 [32], but clearly it cannot compensate fully for the loss
of Rac1 or Cdc42 in melanoblasts.
In summary, Cdc42 is an important regulator of cell migration
and proliferation of melanocytic cells; its loss caused failure of
multiple aspects ofmigration, whichwere not rescued by re-acti-
vation or expression of any single component.
EXPERIMENTAL PROCEDURES
Reagents, Mice, and Genotyping
All animal experiments were performed according to UK Home Office regula-
tions. Genotyping was performed by Transnetyx. All other mouse strains used
were previously described, and all antibody and chemical reagents are
detailed in Supplemental Experimental Procedures.
Melanocyte Isolation, Culture, and Transfection
Primary melanocytes were isolated and purified from the skin of 1-day-old
pups and imaged according to methods previously described [4] and in Sup-
plemental Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
seven figures, six movies, and one dataset and can be found with this article
online at http://dx.doi.org/10.1016/j.cub.2017.01.033.
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